Author

Kathryn M. Tinari

Observed name: Kathryn Tinari

Institutions: University of Chicago, University of Chicago Medical Center

Observed institutions: University of Chicago, University of Chicago Medical Center

OpenAlex ID: A5067633227

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

2020 · Jagoda K. Jasielec, Tadeusz Kubicki, et al. · Blood · 74

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma

2019 · Andrzej J. Jakubowiak, Jagoda K. Jasielec, et al. · British Journal of Haematology · 69

High Rate of Sustained Minimal Residual Disease Negativity Predicts Prolonged Survival for the Overall Patient Population in the Phase 2 KRd Plus Autologous Stem Cell Transplantation MMRC Trial

2017 · Andrzej Jakubowiak, Noopur Raje, et al. · Blood · 10

Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study

2020 · Jagoda Jasielec, Jeff Zonder, et al. · Blood · 4

Works count: 4

Citation count: 157

H-index: 4

I10-index: 3